Product Information
RISEDRONATE SODIUM 35 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $2.3991 per EA under NDC 59762040504. Its NADAC has been published 346 times since Nov 13, 2019.
Strength
30.1; 4.9 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762040504
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RISEDRONATE SODIUM HEMIPENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020835On Market Since
5/17/2002
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SODIUM 35 MG TABLET has been published 346 times since Nov 13, 2019, and over the history we have for it it has declined 58.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3991 per EA |
|---|---|
| All-time high | $5.8238 (Nov 13, 2019) |
| All-time low | $1.1853 (Sep 20, 2023) |
| 52-week high | $2.4340 |
| 52-week low | $1.8164 |
| Median price | $2.4340 |
| Average price | $2.9475 |
| Largest weekly change | +76.8% (Dec 20, 2023) |
| Weeks tracked | 346 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISEDRONATE SODIUM 35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 35 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $2.3991 per EA (NDC 59762040504), effective Jun 24, 2026.
How has the price of RISEDRONATE SODIUM 35 MG TABLET changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SODIUM 35 MG TABLET has declined 58.8%. It has been tracked across 346 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 35 MG TABLET?
Since Nov 13, 2019, the NADAC for RISEDRONATE SODIUM 35 MG TABLET has ranged from a low of $1.1853 (Sep 20, 2023) to a high of $5.8238 (Nov 13, 2019), with a median of $2.4340 per EA.
Are there cheaper alternatives to RISEDRONATE SODIUM 35 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as RISEDRONATE SODIUM 35 MG TABLET, but none are currently priced below it.
Who manufactures RISEDRONATE SODIUM 35 MG TABLET?
RISEDRONATE SODIUM 35 MG TABLET (NDC 59762040504) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification